Inicure AB

Inicure AB is a biotechnology company spun off from Pronoxis AB, established in 2024. The core mission of the organization is to combat the growing global threat of antibiotic resistance. They specialize in developing novel anti-infectious assets based on activating the formyl peptide receptor-1 (FP...